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Eprosartane, in the presence of contraindications for angio-
tensin II - converting enzyme inhibitor Ramipril, is absolutely 
opportune in the presence of hypertensive microalbuminuria.
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Abstract
This paper investigates the influence of the copper coordination compounds CMT-28, CMT-67 and of the bacterial remedy BioR on the cathepsin 
D activity in liver in experimental cirrhosis.  The activity of cathepsin D was also detected electron-histochemicaly in the liver during the regression 
of experimental hepatic cirrhosis.  The result suggests that the coordinative compound CMT-67 used in combination with the bacterial remedy BioR 
has a pronounced stimulating effect on the enzymatic hydrolysis of the extracellular matrix under the action of cathepsin D and contributes to a more 
efficient breakdown of the excessive fibrous tissue in liver.  It was determined that the active cathepsin D is localized intracellularly in the lysosomes of 
hepatocytes, macrophages, fibroblasts and endothelial cells, as well as extracellularly on the collagen fibrils near the parenchymal and mezenchymal cells. 
In addition to its participation in the intracellular proteolysis, cathepsin D is secreted by the hepatocytes and connective tissue cells to the extra-cellular 
space and participates in the extracellular breakdown of the fibrous tissue.
Key words: cathepsin D, liver cirrhosis, coordinative compounds of cuprum, bacterial remedy BioR.
Активность катепсина D при экспериментальном циррозе печени  
и при введении координационных соединений меди и препарата бактериального происхождения BioR
Было изучено влияние координационных соединений меди CMT-28, CMT-67 и препарата бактериального происхождения BioR на 
активность катепсина D в печени при экспериментальном циррозе.  Активность катепсина D была также выявлена электронно-гистохимически 
в печени при регрессии экспериментального цирроза.  Результаты свидетельствуют о том, что координационное соединение меди CMT-67, 
введенное в комбинации с препаратом бактериального происхождения BioR, имеет выраженное стимулирующее влияние на ферментативный 
гидролиз внеклеточного матрикса под влиянием катепсина D и способствует более эффективному распаду фиброзной ткани в печени. 
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Было выявлено, что активный катепсин D локализуется внутриклеточно в лизосомах гепатоцитов, макрофагов и эндотелиальных клеток, 
а также внеклеточно – на коллагеновых волокнах вблизи паренхимальных и мезенхимальных клеток.  Таким образом, помимо участия во 
внутриклеточном протеолизе, катепсин D секретируется гепатоцитами и клетками соединительной ткани во внеклеточное пространство и 
участвует во внеклеточном распаде фиброзной ткани.
Ключевые слова: катепсин D, цирроз печени, координационные соединения меди, препарат бактериального происхождения BioR.
Introduction
Hepatitis and cirrhosis are regional pathologies of Mol-
dova.  Morbidity and mortality caused by these diseases are 
constantly growing.  Liver cirrhosis is a chronic diffuse liver 
disease with diverse etiology, characterized by inflamma-
tory, degenerative, necrotic and concomitant regenerative 
processes, accompanied by progressive disturbances of the 
organ structure and function [1].  The etiologic factor causes 
dystrophy and necrosis of the liver cells, infiltration of the 
portal ducts, cholestasis and connective tissue development. 
Hepatocytes necrosis is followed by the regeneration of some 
of the remaining liver cells that leads to the formation of 
the pseudolobules, which substantially disrupt the normal 
structure of the organ, create circulatory problems that results 
in severe deficiencies in oxygen and nutrients supply to the 
hepatocytes and their continuous damage [2].  Fibrosis – the 
deposition of fibrous connective tissue in excess, which repla-
ces necrotizing parenchyma elements, is the consequence of 
most liver diseases arising from chronic aggression carried out 
by various agents (viral, toxic, immunologic, metabolic) [3]. 
Fibrosis is characterized by a 3-6 fold increase in the amount 
of all extracellular matrix components, some of which will 
increase disproportionately and induce subtle changes of the 
microstructure at the molecular level [4, 5].  It is believed that 
the essential cause of the excessive accumulation of connective 
tissue in the liver is the impaired balance between synthesis 
and degradation of liver extracellular matrix components, 
in particular, collagen, occurring as a result of parenchyma 
damage, blood circulation deficiencies (including, resulting 
hypoxia) caused by the products of the unpaired metabolism. 
Ultimately the self-regulation of the connective tissue is affec-
ted and the biosynthesis of the compounds of the extracellular 
matrix begins to outweigh their catabolism, which provides 
further progression of fibrosis [6].  It is well known that fibro-
genesis insured by the mezenchimal component is balanced 
by fibrolysis that is controlled by the parenchyma cells.  Thus 
the continuing damage of the parenchyma can unbalance the 
fibrogenesis and fibrolysis and evolve to fibrosis [7].
When the cell degeneration starts, the reparative pro-
cesses also begin.  Destructive and reparative processes run 
simultaneously for a long time, thus the necrotized liver tissue 
is replaced by functionally active one.  Mechanisms, which 
provide structural and functional restoration of the liver in 
such conditions, particular reparative metabolic processes in 
the damaged liver tissue are still unknown.
Lysosomal apparatus of the cell with its powerful com-
plex of hydrolases, in particular, cathepsins B, D, G, L, H, 
possesses a particularly important role in adaptive changes 
of the disturbed metabolic processes and structure of organs 
and systems due to the action of exogenous chemicals [8, 
9].  Protective function of lysosomes is manifested by their 
involvement in the intracellular digestion of phagocytized 
macromolecular and supramolecular structures that a sensed 
as foreign compounds as well as degraded intracellular struc-
tures.  Frequently extreme factors increase the activity of in-
tracellular proteolytic enzymes, which lead to the formation of 
biologically active compounds that influence the biosynthesis 
of proteins and nucleic acids [10].
Cathepsin D, considered to be a marker of the lysosomal 
enzymes as acidic phosphatase, is one of the most important 
lysosomal aspartic proteinase and is capable to degrade the 
main components of the intercellular matrix: collagen, proteo-
glycans and glycoproteins (fibronectin).  Cathepsin D attacks 
the non-helical terminal regions of the collagen molecules 
or the α-helical chains, digesting the solubile colagen and 
solubilizing about 10% of the unsoluble colagen at pH 3.3-4.0.
Cathepsin D is involved in the degradation of proteogly-
cans at pH 5.0.  The efficacy of the proteolysis, producer by 
cathepsin D is highest at acidic pH values (2.8 to 5.0), although 
some authors record in vitro high enzymatic activity and a pH 
of 7.2.  This allows supposing that cathepsin D participates not 
only in the intracellular degradation of the proteins, but also 
in their extracellular catabolism, but the later is not proven.
Since the cellular lysosomal system is an important part 
in the body’s enzymatic protection against the aggression of 
foreign substances, the study of the mechanisms of action of 
coordination compounds of transition metals and cyanobac-
terial remedies on lysosomal hydrolyses in the regression of 
experimental liver cirrhosis, is of particular interest especially 
on purpose to use them as versatile medical preparations for 
the morpho-functional recovery of organs affected by fibrosis 
and sclerosis.
The objectives of the study were:
1) The assessment of the changes in cathepsin D activity 
in experimental liver cirrhosis (CH) and after the adminis-
tration of copper coordination compounds (CC) and their 
combinations with BioR.
2) Electron-histochemical detection of cathepsin D acti-
vity in the liver in the process of regression of experimental 
liver cirrhosis.
Material and methods
The biological activity of copper coordination compounds 
CMT-28 and CMT-67 and of their combinations with cyano-
bacterial remedy BioR were evaluated in the experiment on 
a group of animals consisting of 80 male white rats weighing 
200-220g, divided into 8 groups of 10 animals each. The 
first group-control, consisted of 10 animals, maintained on 
a normal vivarium diet and treated with normal saline that 
was injected intramuscularly daily.  Group No. 2-8 consisted 
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of experimental animals that were injected intramuscularly 
50% sol. of carbon tetrachloride (CCl4), 1 mg/kg twice a week, 
over 60 days to induce experimental liver cirrhosis.  Carbon 
tetrachloride (CCl4) enters the body and reacts with amines 
and proteins resulting in the formation of free radicals.  Li-
pid peroxidation by free radicals disturbs the function of the 
cell membranes, including the lysosomal membrane.  This 
will increase the permeability that is considered a universal 
mechanism of cellular damage at membrane level [11, 12].
Animals in group 3 were treated with CMT-28, while those 
in group 4 - the CMT-67.  Animals from group No. 5 were 
subjected to treatment with CMT-28 in combination with 
BioR, and group 6 - CMT-67 in combination with BioR.  All 
those preparations were administered intramuscularly for 
14 and 28 days, the daily dose being of 1.0 g/kg body weight.
Animals in groups 1-6 were sacrificed under light narcosis 
with sulfuric ether 24 hours after the last injection.  Animals 
in groups 7 and 8 were sacrificed 7 and 14 days, respectively, 
after the suspension injections of CCl4.  Biological material - 
the liver, was collected, washed with 0.85% sol. of NaCl and 
dried with filter paper.  Further liver homogenate was prepared 
in 0.25 M sucrose buffer, containing 1 mM EDTA, pH 7.4, so 
the final dilution of homogenate to be 1:10.
Cathepsin D activity was determined in liver homogenate 
according to the procedure described by Barrett A., 1977 
[13], modified by Gudumac V. [14].  The principle of this 
method is based on the enzyme’s ability to make an intense 
hydrolysis with the formation of hemoglobin macromolecule 
acid-soluble derivatives, which can be estimated spectrop-
hotometrically.  Statistical evaluation of biochemical indices 
was made by parametric t-Student criterion with reliability 
less than 0.05 (p < 0.05).
For electron-histochemical determination of cathepsin 
D activity in animal liver at ultra structural level the liver of 
the rats from groups 7 and 8 was processed in accordance 
with the procedure described by Smith and Van Frank [15]. 
Tissue samples with dimensions 0.5×0.5×1.0 mm were fixed 
for 3 hours in 0.05 M cacodilat buffer, pH 7.2 with 1.5% 
glutaraldehyde.  Then during three days the samples were 
washed in 0.05 M cacodilat buffer, pH 7.2, containing 7% 
sucrose.  The substrate for incubation was BZ-Arg-Gly-Phe-
Phe-Pro-4MβNA (Bachem).  Incubation lasted 30 min at 37˚C 
in the medium, which contained 24 mg substrate dissolved in 
1 ml dimethylformamide and 25 ml glycine-HCl buffer, pH 
3.1.  The reaction is stopped by the addition to the reaction 
medium of 10% KOH with subsequent washing with HEPES 
buffer, pH 7.0 and was followed by the incubation in pH 
5.4 cacodilate buffer with dipeptidil-aminopeptidase II and 
para-roseaniline at 37˚C for 15 min.  After the incubation 
the material was fixed with 1.5% sol. osmium tetraoxide in 
cacodilat in buffer (pH 7.2) for 90 min.  In the usual manner 
for electron microscopy examination, the exploratory material 
was dehydrated in ethyl alcohol solutions with increasing 
concentrations (50%, 70%, 96%, and 100%) and then incu-
bated for 20 min in absolute acetone.  Samples were included 
in the eponymous and left in the thermostat at 60˚C for 24 
hours.  As reference, material was used the tissue incubated 
without substrate.
Results and discussions
The results of the research, illustrated in figure 1, have 
shown that in animals with experimental liver cirrhosis in-
duced by CCl4, activity of cathepsin D increase statistically 
significant by 27% compared to the control group.  Knowing 
the properties of this proteolytic enzyme and its ability to 
initiate protein degradation, in particular collagen, we can 
assume that the increased activity of cathepsin D at the stage 
of maximal cirrhosis development is a manifestation of the 
fact that in the liver, parallel with fibrogenesis process runs fi-
brolysis for the degradation of the excessive connective tissue.
Administration of the bioremedy BioR in dose of 1 mg/kg 
did not affect the enzyme activity, maintaining it practical at 
the control levels.  At the same time, administration of BioR 
in the dose 2 mg/kg maintains the enzyme activity at levels 
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Fig. 1. Changes in cathepsin D activity (%) in liver cirrhosis
and administration of CC and their combinations BioR.
Administration of the bioremedy BioR in dose of 1 mg/kg did not affect the enzyme activity, 
maintaining it practical at the control levels. At the same time, administration of BioR in the dose 2 
mg/kg maintains the enzyme activity at levels similar to those assessed in the group of animals with LC
and is 31% higher then the control levels. After the treatment with copper coordination compound
CMT-28 the activity of cathepsin D showed a tendency to decrease by 10% in animals intoxicated with 
CCl4. At the same time, the combined use of CMT-28 and BioR does not change the functional level 
of the enzyme in the liver of the animals with cirrhosis, which was by 27% higher comparative with the 
original level. The copper coordination compound CMT-67 reduces the degree of cathepsin D activity
induction, triggered by cirrhosis, maintaining it at normal values. At the same time combined 
medication with CMT-67 and BioR increases statistically significant the enzyme activity by 49% (p <
0.05) compared with healthy animals and by 17% compared with rats with cirrhosis.
The enhancement of the activity of cathepsin D under the combined influence of CMT-67 and 
BioR can be considered as a compensatory adaptation reaction of the body, which tends to amplify the 
biodegradation of defective molecules, resulting from harmful action of CCl4 on liver tissue. The 
combined administration of copper coordination compound CMT-67 with cyanobacterial remedy BioR 
exercise pronounced stimulatory effect on the process of enzymatic hydrolysis of liver extracellular 
matrix compounds, contributing to a more efficient degradation of fibrous tissue, which is 
demonstrated by inducing the expression of cathepsin D. The results of the study showed that the 
investigated remedies have selective action on cathepsin D activity.
Electron-histochemical detection of cathepsin D activity in the liver in the process of 
experimental liver cirrhosis regression. In order to elucidate the participation of cathepsin D in the 
resorption of the connective tissue in the liver, we performed electron-histochemical detection of 
cathepsin D. We studied the distribution of the enzyme activity in the liver at the ultrastructural level 
within two weeks after cessation of intoxication.
The cathepsin D reaction product was detected in the lysosomes of the hepatocytes, macrophages 
and fibroblasts 7 and 14 day after cessation of CCl4 administration by electron-histochemical 
investigation. A pronounced reaction was detected in the lysosomes of endothelial cells, too (fig. 2). It 
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Fig. 1.  Changes in cathepsin D activity (%)  
in liver cirrhosis and administration of CC  
and their combinations BioR.
similar to those assessed in the group of animals with LC and 
is 31% higher then the control levels.  After the treatment 
with copper coordination compound CMT-28 the activity of 
cathepsin D showed a t ndency to dec ease by 10% in animals 
intoxicated with CCl4.  At the same tim , the combined use 
of CMT-28 and BioR does not change the functional level of 
the enzyme in the liver of the animals with cirrhosis, which 
was by 27% higher comparative with the original level.  The 
copper coordination compound CMT-67 reduces the degree 
of cathepsin D ctivity induction, triggered by cirrhosi , 
maintaining it at normal values.  At the same time combined 
medication with CMT-67 and BioR increases statistically sig-
nificant the enzyme activity by 49% (p < 0.05) compared with 
healthy animals and by 17% compared with rats with cirrhosis.
The enhancement of the activity of cathepsin D under the 
combined influenc  of CMT-67 and BioR can be considered as 
a compensatory adaptation reaction of the body, which tends 
to amplify the biodegradation of defective molecules, resulting 
from harmful action of CCl4 on liver tissue.  The combined 
administration of copper coordination compound CMT-
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67 with cyanobacterial remedy BioR exercise pronounced 
stimulatory effect on the process of enzymatic hydrolysis of 
liver extracellular matrix compounds, contributing to a more 
efficient degradation of fibrous tissue, which is demonstrated 
by inducing the expression of cathepsin D.  The results of the 
study showed that the investigated remedies have selective 
action on cathepsin D activity.
Electron-histochemical detection of cathepsin D activity in 
the liver in the process of experimental liver cirrhosis regression. 
In order to elucidate the participation of cathepsin D in the 
resorption of the connective tissue in the liver, we perfor-
med electron-histochemical detection of cathepsin D.  We 
studied the distribution of the enzyme activity in the liver at 
the ultrastructural level within two weeks after cessation of 
intoxication.
The cathepsin D reaction product was detected in the 
lysosomes of the hepatocytes, macrophages and fibroblasts 7 
and 14 day after cessation of CCl4 administration by electron-
histochemical investigation. A pronounced reaction was de-
tected in the lysosomes of endothelial cells, too (fig. 2).  It was 
noted a marked heterogeneity in the distribution of reaction 
product within different cell types and between lysosomes 
belonging to the same cell.  A maximal expressed activity was 
seen in macrophages (fig. 3) and fibroblasts in all periods of 
investigation.  The activity of cathepsin D was often detected 
in the myelin-type structures and in the autophagy vacuoles 
of the hepatocytes after 7 days of regression of cirrhosis.
A major result of our study was the electron-histochemical 
detection of extracellular activity of cathepsin D at both 
studied stages of cirrhosis regression.  The reaction product 
is preferentially located on the collagen fibrils near the hepa-
tocytes and cellular elements of connective tissue and, also, 
on the hepatocytes microvilli and on the external surface of 
the Kupffer cells cytolemma (fig. 2, 3).  Therefore, both pa-
renchymal cells and connective tissue cellular elements are 
sources of extracellular cathepsin D.
The electron-histochemical investigations of samples 
of liver tissue in the process of regression of cirrhosis have 
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was noted a marked heterogeneity in the distribution of reaction product within different cell types and 
between lysosomes belonging to the same cell. A maximal expressed activity was seen in macrophages 
(fig. 3) and fibroblasts in all periods of investigation. The activity of cathepsin D was often detected in
the myelin-type structures and in the autophagy vacuoles of the hepatocytes after 7 days of regression 
of cirrhosis.
Fig. 2. 14-th day of experimental cirrhosis regression.
A pronounced reaction on cathepsin D (arrows) in the 
lysosome of endothelial cell (En), and extracellular on 
hepatocytes microvilli (H). x 20000.
Fig. 3.  14-th day of experimental cirrhosis regression. 
Reaction on cathepsin D (arrows) in the lysosome of 
Kupffer cell, and extracellular on the cytolemma.
x 20000.
A major result of our study was the electron-histochemical detection of extracellular activity of
cathepsin D at both studied stages of cirrhosis regression. The reaction product is preferentially located
on the collagen fibrils near the hepatocytes and cellular elements of connective tissue and, also, on the 
hepatocytes microvilli and on the external surface of the Kupffer cells cytolemma (fig. 2, 3).
Therefore, both parenchymal cells and connective tissue cellular elements are sources of extracellular 
cath psin D.
The el ctro -histochemical investigations of samples of liver tissue in the process of regression of 
cirrhosis have revealed the intracellular localization of cathepsin D - in the lysosomes of the
hepatocytes, macrophages, fibroblasts and endothelial cells, and the extracellular localization - on the
collagen fibrils near the parenchymal and mesenchyme cells. The heterogeneity of distribution and 
intensity of the reaction product, observed in our study reveals different functional status of the 
lysosomal system, belonging to different cell types.
Extracellular cathepsin D activity d tected in the liver damaged by cirrhosis reveals that besides 
being involved n intracellular proteolysis, c th psin D is secreted by hepatocytes and cellular elements 
of conn ctive tissue i  the intercellular space and participates in the catabolism of hepatic extracellular 
matrix and extracellular resorption of fibrous tissue. The important role of cathepsin D was established 
in liver cell division process during liver regeneration [10].
Therefore, increased activity of the studied proteinase during the regression of the liver pathology 
could be required for both degradation of connective tissue formed in excess and/or damaged cell 
structures, and to provide processes of cell division.
Conclusions
1. Administration of the ombination of copper coordination compound CMT-67 with 
cyanoba terial remedy BioR exhibited a pronounced stimulatory effect on the enzymatic 
hydrolysis processes of liver extracellular matrix under the action of cathepsin D, contributing to 
the more efficient degradation of the excessive fibrous tissue.
Fig. 2.  14-th day of experimental cirrhosis regression. 
A pronounced reaction on cathepsin D (arrows) in the 
lysosome of endoth lial cell (En), and extrac llular  
hepatocytes microvilli (H).  x 20000. 
Fig. 3.  14-th day of experimental cirrhosis regression. 
Reaction on cathepsin D (arrows) in the lysosome of 
Kupffer cell, and extracellular on the cytolemma. x 20000.
revealed the intracellular localization of cathepsin D - in 
the lysosomes of the hepatocytes, macrophages, fibroblasts 
and endothelial cells, and the extracellular localization - on 
the collagen fibrils near the parenchymal and mesenchyme 
cells.  The heterogeneity of distribution and intensity of the 
reaction product, observed in our study reveals different 
functional status of the lysosomal system, belonging to 
different cell types.
Extracellular cathepsin D activity detected in the liver 
damaged by cirrhosis reveals that besides being involved in in-
tracellular proteoly is, cathepsin D is secreted by hepatocytes 
and cellular elements of connective tissue in the intercellular 
space and participates in the catabolism of hepatic extracel-
lular matrix and extracellular resorption of fibrous tissue. 
The important role of cathepsin D was established in liver cell 
division process during liver regeneration [10].
Therefore, increased activity of the studied proteinase 
during the regression of the liver pathology could be required 
for both degradation of c nnective tissue formed in xcess 
and/or damaged cell structures, and to provide processes of 
cell division.
Conclusions
1. Administration of the combination of copper coordi-
nation compound CMT-67 with cyanobacterial remedy BioR 
exhibited a pronounced stimulatory effect on the enzymatic 
hydr ly is processes of liver extracellular matrix under the 
action of cathepsin D, contributi g to the more efficient 
degradation of the excessive fibrous tissue.
2. Active cathepsin D is localized intracellular in the 
lysosomes of the hepatocytes, macrophages, fibroblasts and 
endothelial cells and extracellular – on the collagen fibrils 
near the parenchymal and mesenchyme cells.
3. In addition to its involvement in the intracellular 
proteolysis, cathepsin D is secreted by the hepatocytes and 
connective tissue cellular elements into the intercellular 
space and participates in the extracellular resorption of 
the fibrous tissue.
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Abstract
Despite all recent efforts, cancer of the uterine cervix still remains one of the most frequent malignancies among women.  Lymphatic vessels represent 
the primary route of tumor cells dissemination in cervical cancer.  It has been demonstrated that cervical neoplasia actively participates in the recruitment 
of new blood and lymphatic vessels.  Macrophages are extremely versatile cells which have a significant contribution to tumor progression.  The aim: 1) 
To establish the correlation between tumor-associated macrophages (TAM) and the grade of the uterine cervix neoplasia; 2) To evaluate the distribution 
of TAM within both intratumoral and peritumoral areas.  Material and Methods: Ninety-six cases were studied.  The specimens were fixed in buffered 
formalin and paraffin embedded.  Step sections, 5µm thick, were performed for each case. Initial sections were stained with haematoxylin-eosin, for 
the pathological diagnosis and grading of the tumor.  Lesions were classified as follows: squamous cell metaplasia (n = 12), CIN I (n = 8), CIN II (n = 
6), CIN III (n = 24), microinvasive carcinoma (n = 16) and invasive squamous cell carcinoma (n = 26).  Additional sections for each case were stained 
for CD68 antibody, in order to highlight the macrophages.  Quantification of macrophage population has been made based on hot-spot technique.  The 
arithmetic media of 3 (× 200) fields represented the final result.  Results: We found a statistical correlation between peritumoral macrophages (PTM) 
and intratumoral macrophages in all stages of cervical neoplasia, macrophage density and tumor stage (p = 0.01).  In 16 cases we found vascular invasion. 
Almost in all these cases (87.5%) intravascular tumor emboli were embedded with CD68+ cells.  Conclusions: based on these findings, we consider that 
macrophages are key regulators of cervical cancer progression.  TAM targeted management could be an essential therapeutic strategy, not only in order 
to suppress the progression of cervical neoplasia, but also to inhibit macrophage-mediated vascular invasion.
Key words: uterine cervix cancer, macrophages, cellular density, tumor progression, CD68.
Корреляция плотности макрофагов с тяжестью неоплазии шейки матки
Рак шейки матки остается одной из самых часто встречающихся злокачественных заболеваний женского населения.  Лимфатические 
сосуды являются первичным путем метастазирования при данном заболевании.  Было доказано, что клетки цервикальной неоплазии активно 
участвуют в образовании новых лимфатических сосудов.  Макрофаги – многофункциональные клетки, оказывающие большое влияние 
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